News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,762 Results
Type
Article (13964)
Company Profile (102)
Press Release (256696)
Section
Business (89540)
Career Advice (466)
Deals (15727)
Drug Delivery (66)
Drug Development (37160)
Employer Resources (49)
FDA (6414)
Job Trends (6263)
News (152882)
Policy (14271)
Tag
Academia (448)
Alliances (23948)
Alzheimer's disease (382)
Approvals (6432)
Artificial intelligence (92)
Bankruptcy (146)
Best Places to Work (4430)
Breast cancer (74)
Cancer (527)
Cardiovascular disease (54)
Career advice (407)
Cell therapy (75)
Clinical research (31231)
Collaboration (289)
Compensation (116)
COVID-19 (767)
C-suite (96)
Data (527)
Diabetes (68)
Diagnostics (1394)
Drug discovery (48)
Drug pricing (61)
Earnings (32209)
Events (37795)
Executive appointments (323)
FDA (6744)
Funding (184)
Gene therapy (91)
GLP-1 (327)
Government (1295)
Healthcare (3742)
Infectious disease (795)
Inflammatory bowel disease (54)
Interviews (60)
IPO (5952)
Job creations (2064)
Job search strategy (373)
Layoffs (175)
Legal (3514)
Lung cancer (72)
Manufacturing (128)
Medical device (1422)
Medtech (1424)
Mergers & acquisitions (9922)
Metabolic disorders (218)
Neuroscience (529)
NextGen: Class of 2025 (1610)
Non-profit (594)
Northern California (623)
Obesity (124)
Opinion (116)
Patents (91)
People (29089)
Pharmaceutical (64)
Phase I (8175)
Phase II (13228)
Phase III (11806)
Pipeline (297)
Policy (53)
Postmarket research (1427)
Preclinical (3255)
Radiopharmaceuticals (122)
Rare diseases (150)
Real estate (2693)
Regulatory (10175)
Research institute (577)
Resumes & cover letters (55)
Southern California (614)
Startups (1667)
United States (6232)
Vaccines (136)
Weight loss (89)
Date
Today (8)
Last 7 days (288)
Last 30 days (1015)
Last 365 days (12530)
2025 (2047)
2024 (12720)
2023 (14535)
2022 (20466)
2021 (20944)
2020 (19645)
2019 (15254)
2018 (11938)
2017 (14222)
2016 (13421)
2015 (15858)
2014 (12716)
2013 (10822)
2012 (11682)
2011 (12164)
2010 (11098)
Location
Africa (314)
Asia (20296)
Australia (2708)
California (1487)
Canada (815)
China (193)
Colorado (61)
Connecticut (61)
Delaware (48)
Europe (42143)
Florida (266)
Illinois (166)
Indiana (118)
Japan (79)
Kansas (53)
Maryland (227)
Massachusetts (1286)
Minnesota (81)
New Jersey (638)
New York (423)
North Carolina (353)
Northern California (623)
Pennsylvania (382)
South America (504)
Southern California (614)
Texas (196)
Virginia (62)
Washington State (101)
270,762 Results for "biofrontera pharmaceuticals gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
Biofrontera Inc. today announced the restructuring of agreements between the Company and its former parent company Biofrontera AG.
February 20, 2024
·
5 min read
Press Releases
Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market
December 23, 2024
·
5 min read
Genetown
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.
June 24, 2024
·
5 min read
Business
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatologic products, reported financial results for the three months ended March 31, 2024 and provided a business update.
May 15, 2024
·
11 min read
Press Releases
Biofrontera Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
December 3, 2024
·
4 min read
Press Releases
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note
November 25, 2024
·
3 min read
Press Releases
Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)
January 8, 2025
·
5 min read
Regulatory
FDA Action Alert: Biofrontera, BMS and Zealand
One upcoming decision—on a perioperative PD-1 regimen for lung cancer—comes as the FDA considers an overhaul of trial designs in this treatment setting.
September 30, 2024
·
4 min read
·
Tristan Manalac
Business
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024.
May 6, 2024
·
1 min read
Press Releases
Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024
November 1, 2024
·
1 min read
1 of 27,077
Next
